EMA publishes new GDP non-compliance report for wholesaler in Norway
Recommendation

6/7 May 2026
Copenhagen, Denmark
The European Database EudraGMDP doesn't only contain GMP, but also GDP reports of non-compliance. The Norwegian Authority has issued a statement of non-compliance with GDP for medicinal products of the company Norges NaturmedisinSentral AS, Terminalen 9, Bachetomta næringspark, Lierstranda industriområde, LIER, NO-3414, Norway.
The company was involved in the distribution of medicinal products requiring cold storage and transportation. These operations were not managed under GDP. As a consequence the WDA (Wholesale Distributor Authorisation) has been partly withdrawn. Cold chain activities are now no longer permitted.
Source: EudraGMDP Database (GDP Non-Compliance Report)
Related GMP News
21.04.2026Implementation of GDP for Pharmaceutical Products in Hong Kong
21.04.2026China's NMPA: Guiding Opinions & Q&A on Standardising Modern Pharmaceutical Logistics
21.04.2026GMDP IWG Three-Year Work Plan: What's Planned for GDP?
21.04.2026Questions and Answers from the ECA Webinar "GDP Update 2026" - Part 2
25.03.2026What is Good Distribution Practice (GDP)?
24.03.2026What Requirements must a Responsible Person for GDP meet?


